Dynavax Responds to Glass Lewis Report
| Field | Detail |
|---|---|
| Company | Dynavax Technologies Corp |
| Form Type | DEFA14A |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, response, regulatory
TL;DR
Dynavax fires back at Glass Lewis report, no fee paid.
AI Summary
Dynavax Technologies Corporation filed a DEFA14A on June 6, 2025, in response to a report from Glass, Lewis & Co. The filing indicates no fee was required for this submission. The company is headquartered in Emeryville, CA, and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing is important as it represents Dynavax's official response to a third-party analysis, potentially influencing investor perception and voting decisions.
Risk Assessment
Risk Level: low — The filing is a routine response to a proxy advisory firm's report and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Dynavax Technologies Corporation (company) — Registrant
- Glass, Lewis & Co. (company) — Report Issuer
- 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 (company) — Business and Mail Address
FAQ
What is the purpose of this DEFA14A filing?
The purpose of this DEFA14A filing is for Dynavax Technologies Corporation to submit a statement in response to a report issued by Glass, Lewis & Co.
When was this filing submitted?
This filing was submitted on June 6, 2025.
Who is the registrant in this filing?
The registrant is Dynavax Technologies Corporation.
What is the standard industrial classification for Dynavax Technologies Corporation?
The standard industrial classification for Dynavax Technologies Corporation is Pharmaceutical Preparations [2834].
Was there a fee required for this filing?
No fee was required for this filing, as indicated by the 'No fee required' checkbox being selected.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 6, 2025 regarding DYNAVAX TECHNOLOGIES CORP.